MARIETTA, Ga. , June 7, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that John D. Harris has joined the Company as its Senior Vice President of International, and also provided an update on the
Company to Restate Financial Statements for Fiscal Years 2012 through 2016, and Interim Periods of 2017 Related to Revenue Recognition Appoints Interim Chief Financial Officer Business Performance Remains Strong MARIETTA, Ga. , June 7, 2018 /PRNewswire/ -- MiMedx Group, Inc.
MARIETTA, Ga. , May 18, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that it received written notification, as expected, from the NASDAQ Stock Market that the Company continues to be in
MARIETTA, Ga. , May 10, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, announced today that it will participate in the Bank of America Merrill Lynch 2018 Healthcare Conference in Las Vegas, Nevada . Christopher M.
MARIETTA, Ga. , May 10, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today commented on the indictment filed in the United States District Court for the District of South Carolina against individuals previously
COMPANY ANNOUNCES ITS REVENUE GUIDANCE FOR SECOND QUARTER AND INCREASES FULL YEAR REVENUE GUIDANCE MARIETTA, Ga. , April 26, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced certain unreviewed results
MARIETTA, Ga. , April 23, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, announced that the Company will host its live broadcast of the Company's first quarter conference call on April 26, 2018 at 10:30 a.m.
Breakfast Symposium to Underscore Statistically Significant Evidence of EpiFix® in Healing DFUs and VLUs MARIETTA, Ga. , April 23, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced the Company's
Initiation of Phase 2B Study Follows Quickly After FDA Grants RMAT Designation for Knee OA MARIETTA, Ga. , March 28, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that the first patient has been
MARIETTA, Ga. , March 26, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, announced today that it will participate in the 17th Annual Needham Healthcare Conference in New York on Wednesday, March 28, 2018 .
